Stocks and Investing Stocks and Investing
Wed, July 3, 2024

Joseph Catanzaro Maintained (BDTX) at Buy and Held Target at $12 on, Jul 3rd, 2024


Published on 2024-10-28 12:14:05 - WOPRAI, Joseph Catanzaro
  Print publication without navigation


Joseph Catanzaro of Piper Sandler, Maintained "Black Diamond Therapeutics, Inc." (BDTX) at Buy and Held Target at $12 on, Jul 3rd, 2024.

Joseph has made no other calls on BDTX in the last 4 months.



There are 2 other peers that have a rating on BDTX. Out of the 2 peers that are also analyzing BDTX, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Joseph


  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $11 on, Friday, June 7th, 2024
  • Robert Driscoll of "Wedbush" Maintained at Buy with Increased Target to $16 on, Monday, April 8th, 2024
Contributing Sources